logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 6
  • 1
    Manson, Richard John
    Born in May 1992
    Individual (3 offsprings)
    Officer
    2023-03-21 ~ now
    OF - Director → CIF 0
  • 2
    Gallagher, Alan
    Born in August 1985
    Individual (1 offspring)
    Officer
    2025-03-21 ~ now
    OF - Director → CIF 0
  • 3
    Manson, Lynn Iris Muriel
    Born in May 1961
    Individual (5 offsprings)
    Officer
    2023-03-21 ~ now
    OF - Director → CIF 0
  • 4
    Manson, Kenneth Mcdonald
    Born in October 1960
    Individual (5 offsprings)
    Officer
    2023-03-21 ~ now
    OF - Director → CIF 0
  • 5
    Manson, Peter James
    Born in October 1990
    Individual (3 offsprings)
    Officer
    2023-03-21 ~ now
    OF - Director → CIF 0
  • 6
    KEMNAY PHARMACY LIMITED
    SC245230
    18, North Silver Street, Aberdeen, United Kingdom
    Active Corporate (6 parents, 3 offsprings)
    Person with significant control
    2023-03-21 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
parent relation
Company in focus

GALLAGHER PHARMA LIMITED

Period: 2023-03-21 ~ now
Company number: SC763100
Registered name
GALLAGHER PHARMA LIMITED - now
Standard Industrial Classification
47730 - Dispensing Chemist In Specialised Stores
Brief company account
Average Number of Employees
02024-04-01 ~ 2025-03-31
92023-03-21 ~ 2024-03-31
Par Value of Share
Class 1 ordinary share
12024-04-01 ~ 2025-03-31
Intangible Assets
575,294 GBP2025-03-31
645,739 GBP2024-03-31
Property, Plant & Equipment
31,187 GBP2025-03-31
33,562 GBP2024-03-31
Fixed Assets
606,481 GBP2025-03-31
679,301 GBP2024-03-31
Total Inventories
50,109 GBP2025-03-31
53,973 GBP2024-03-31
Debtors
161,774 GBP2025-03-31
175,013 GBP2024-03-31
Cash at bank and in hand
220,011 GBP2025-03-31
189,699 GBP2024-03-31
Current Assets
440,268 GBP2025-03-31
425,866 GBP2024-03-31
Creditors
Current
928,865 GBP2025-03-31
1,061,063 GBP2024-03-31
Net Current Assets/Liabilities
-488,597 GBP2025-03-31
-635,197 GBP2024-03-31
Total Assets Less Current Liabilities
117,884 GBP2025-03-31
44,104 GBP2024-03-31
Net Assets/Liabilities
110,087 GBP2025-03-31
35,713 GBP2024-03-31
Equity
Called up share capital
100 GBP2025-03-31
100 GBP2024-03-31
Retained earnings (accumulated losses)
109,987 GBP2025-03-31
35,613 GBP2024-03-31
Equity
110,087 GBP2025-03-31
35,713 GBP2024-03-31
Intangible Assets - Gross Cost
Net goodwill
704,442 GBP2024-03-31
Intangible Assets - Accumulated Amortisation & Impairment
Net goodwill
129,148 GBP2025-03-31
58,703 GBP2024-03-31
Intangible Assets - Increase From Amortisation Charge for Year
Net goodwill
70,445 GBP2024-04-01 ~ 2025-03-31
Intangible Assets
Net goodwill
575,294 GBP2025-03-31
645,739 GBP2024-03-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
44,990 GBP2025-03-31
39,887 GBP2024-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
13,803 GBP2025-03-31
6,325 GBP2024-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
7,478 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment
Plant and equipment
31,187 GBP2025-03-31
33,562 GBP2024-03-31
Trade Debtors/Trade Receivables
Current
126,051 GBP2025-03-31
141,895 GBP2024-03-31
Other Debtors
Current
20,000 GBP2025-03-31
33,118 GBP2024-03-31
Amount of value-added tax that is recoverable
Current
15,723 GBP2025-03-31
Debtors
Amounts falling due within one year, Current
161,774 GBP2025-03-31
Current, Amounts falling due within one year
175,013 GBP2024-03-31
Trade Creditors/Trade Payables
Current
152,179 GBP2025-03-31
154,921 GBP2024-03-31
Amounts owed to group undertakings
Current
724,436 GBP2025-03-31
866,290 GBP2024-03-31
Corporation Tax Payable
Current
48,901 GBP2025-03-31
23,090 GBP2024-03-31
Other Taxation & Social Security Payable
Current
7,060 GBP2024-03-31
Other Creditors
Current
596 GBP2025-03-31
154 GBP2024-03-31
Accrued Liabilities/Deferred Income
Current
2,753 GBP2025-03-31
9,548 GBP2024-03-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
100 shares2025-03-31

  • GALLAGHER PHARMA LIMITED
    Info
    Registered number SC763100
    18 North Silver Street, Aberdeen AB10 1JU
    PRIVATE LIMITED COMPANY incorporated on 2023-03-21 (3 years 1 month). The status of the company number is Active.
    The last date of confirmation statement was made at 2026-03-20
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 5 April 2026 and licensed under the Open Government Licence v3.0.